Stock Events

Stock Events

Kuros Biosciences 

€27.9
0
+€0.7+2.57% Today

Statistics

Day High
27.9
Day Low
27.9
52W High
36.5
52W Low
1.75
Volume
0
Avg. Volume
3
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10MarExpected
Q4 2025
0
0.33
0.67
1
Expected EPS
0
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow YTSN.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Orthofix Medical
OFIX
Mkt Cap510.64M
Orthofix Medical Inc. provides orthopedic and spine products, directly competing with Kuros in the field of bone healing and regeneration.
Stryker
SYK
Mkt Cap129.89B
Stryker Corporation offers a range of medical technologies, including orthobiologics, which competes with Kuros Biosciences' offerings.
Zimmer Biomet
ZBH
Mkt Cap18.22B
Zimmer Biomet Holdings, Inc. is a leader in musculoskeletal healthcare, competing in the orthobiologics space similar to Kuros.
Medtronic
MDT
Mkt Cap111.97B
Medtronic PLC provides medical technologies, systems, and services, including bone graft solutions that compete with Kuros Biosciences.
Johnson & Johnson
JNJ
Mkt Cap574.66B
Johnson & Johnson, through its DePuy Synthes division, offers products that compete in the orthopedic and spine sector against Kuros.
Baxter International
BAX
Mkt Cap8.85B
Baxter International Inc. produces medical products including biosurgery materials that compete with Kuros Biosciences' surgical solutions.
Boston Scientific
BSX
Mkt Cap91.83B
Boston Scientific Corporation develops medical devices that are used in various surgical applications, competing with Kuros' biosurgery products.

About

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone grafts that mimic the porous and trabecular structure of cancellous bone, as well as checkmate licensing. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.
Show more...
CEO
Mr. Christopher T. Fair B.B.A.
Employees
178
Country
Switzerland
ISIN
CH0325814116

Listings

SW
CH
KURN.SW
MU
DE
YTSN.MU
OTC Link
US
CSBTF
LSE
GB
0RHR.LSE

0 Comments

Share your thoughts

FAQ

What is Kuros Biosciences stock price today?▼
The current price of YTSN.MU is €27.9 EUR — it has increased by +2.57% in the past 24 hours. Watch Kuros Biosciences stock price performance more closely on the chart.
What is Kuros Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Kuros Biosciences stocks are traded under the ticker YTSN.MU.
When is the next Kuros Biosciences earnings date?▼
Kuros Biosciences is going to release the next earnings report on August 13, 2026.
How many employees does Kuros Biosciences have?▼
As of April 15, 2026, the company has 178 employees.
In which sector is Kuros Biosciences located?▼
Kuros Biosciences operates in the Health & Wellness sector.
When did Kuros Biosciences complete a stock split?▼
Kuros Biosciences has not had any recent stock splits.
Where is Kuros Biosciences headquartered?▼
Kuros Biosciences is headquartered in Schlieren, Switzerland.